Literature DB >> 26562240

Imaging of Ancient Egyptian Animal Mummies.

Lidija M McKnight1, Stephanie D Atherton-Woolham1, Judith E Adams1.   

Abstract

Human mummies have long been studied by using imaging as a primary investigative method. Mummified animal remains from ancient Egypt are less well researched, yet much can be learned about species diversity and the methods of preservation. Noninvasive imaging methods enable mummy bundles to remain intact, with no detrimental physical effects, thus ensuring protection of a valuable archaeological resource. This article is based on the research experience gathered during 13 years (2000-2012) with 152 animal mummies held in the collections of 17 museums in the United Kingdom. Conventional radiography, computed radiography, digital radiography, and computed tomography (CT) available in the clinical setting were used to assess the value of each imaging modality in the study of animal mummies and related material. Radiography proved to be an excellent research method that provided initial insight into the contents of the mummy bundle, and CT contributed additional useful detail in some cases. Paleoradiologic analyses enabled information on mummy bundle contents to be proved, including the nature of the skeletal remains and the methods of mummification. An optimum method involving radiography and CT is described. (©)RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26562240     DOI: 10.1148/rg.2015140309

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  2 in total

1.  Alumina as a Computed Tomography Soft Material and Tissue Fiducial Marker.

Authors:  S E Stephens; N B Ingels; J F Wenk; M O Jensen
Journal:  Exp Mech       Date:  2022-01-25       Impact factor: 2.794

2.  Synchrotron "virtual archaeozoology" reveals how Ancient Egyptians prepared a decaying crocodile cadaver for mummification.

Authors:  Camille Berruyer; Stéphanie M Porcier; Paul Tafforeau
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.